Literature DB >> 33383586

CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018.

Jennifer S Lee1, Elizabeth A Humes1, Brenna C Hogan1, Kate Buchacz2, Joseph J Eron3, M John Gill4, Timothy R Sterling5, Peter F Rebeiro5,6, Viviane Dias Lima7, Angel Mayor8, Michael J Silverberg9, Michael A Horberg10, Richard D Moore11, Keri N Althoff1.   

Abstract

From 2005 to 2018, among 32013 adults with human immunodeficiency virus entering care, median time to antiretroviral therapy (ART) prescription declined from 69 to 6 days, CD4 count at entry into care increased from 300 to 362 cells/μL, and CD4 count at ART prescription increased from 160 to 364 cells/μL.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD4 count; HIV; antiretroviral therapy; treat all; universal treatment

Mesh：

Substances：

Year:  2021        PMID： 33383586      PMCID： PMC8492212          DOI： 10.1093/cid/ciaa1904

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  9 in total

1.  Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Authors:  Stephen J Gange; Mari M Kitahata; Michael S Saag; David R Bangsberg; Ronald J Bosch; John T Brooks; Liviana Calzavara; Steven G Deeks; Joseph J Eron; Kelly A Gebo; M John Gill; David W Haas; Robert S Hogg; Michael A Horberg; Lisa P Jacobson; Amy C Justice; Gregory D Kirk; Marina B Klein; Jeffrey N Martin; Rosemary G McKaig; Benigno Rodriguez; Sean B Rourke; Timothy R Sterling; Aimee M Freeman; Richard D Moore
Journal:  Int J Epidemiol       Date:  2007-01-08       Impact factor: 7.196

2.  Ending the HIV Epidemic: A Plan for the United States.

Authors:  Anthony S Fauci; Robert R Redfield; George Sigounas; Michael D Weahkee; Brett P Giroir
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

Review 3.  Challenges and successes in linking HIV-infected women to care in the United States.

Authors:  Mariam Aziz; Kimberly Y Smith
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

4.  Barriers and facilitators to testing, treatment entry, and engagement in care by HIV-positive women of color.

Authors:  Lynne C Messer; E Byrd Quinlivan; Heather Parnell; Katya Roytburd; Adaora A Adimora; Natasha Bowditch; Nancy DeSousa
Journal:  AIDS Patient Care STDS       Date:  2013-07       Impact factor: 5.078

5.  U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.

Authors:  Keri N Althoff; Kate Buchacz; H Irene Hall; Jinbing Zhang; David B Hanna; Peter Rebeiro; Stephen J Gange; Richard D Moore; Mari M Kitahata; Kelly A Gebo; Jeffrey Martin; Amy C Justice; Michael A Horberg; Robert S Hogg; Timothy R Sterling; Angela Cescon; Marina B Klein; Jennifer E Thorne; Heidi M Crane; Michael J Mugavero; Sonia Napravnik; Gregory D Kirk; Lisa P Jacobson; John T Brooks
Journal:  Ann Intern Med       Date:  2012-09-04       Impact factor: 25.391

6.  Effect of early versus deferred antiretroviral therapy for HIV on survival.

Authors:  Mari M Kitahata; Stephen J Gange; Alison G Abraham; Barry Merriman; Michael S Saag; Amy C Justice; Robert S Hogg; Steven G Deeks; Joseph J Eron; John T Brooks; Sean B Rourke; M John Gill; Ronald J Bosch; Jeffrey N Martin; Marina B Klein; Lisa P Jacobson; Benigno Rodriguez; Timothy R Sterling; Gregory D Kirk; Sonia Napravnik; Anita R Rachlis; Liviana M Calzavara; Michael A Horberg; Michael J Silverberg; Kelly A Gebo; James J Goedert; Constance A Benson; Ann C Collier; Stephen E Van Rompaey; Heidi M Crane; Rosemary G McKaig; Bryan Lau; Aimee M Freeman; Richard D Moore
Journal:  N Engl J Med       Date:  2009-04-01       Impact factor: 91.245

7.  Mind the gap: observation windows to define periods of event ascertainment as a quality control method for longitudinal electronic health record data.

Authors:  Keri N Althoff; Cherise Wong; Brenna Hogan; Fidel Desir; Bin You; Elizabeth Humes; Jinbing Zhang; Yuezhou Jing; Sharada Modur; Jennifer S Lee; Aimee Freeman; Mari Kitahata; Stephen Van Rompaey; W Christopher Mathews; Michael A Horberg; Michael J Silverberg; Angel M Mayor; Kate Salters; Richard D Moore; Stephen J Gange
Journal:  Ann Epidemiol       Date:  2019-03-04       Impact factor: 3.797

8.  Critical race theory as a tool for understanding poor engagement along the HIV care continuum among African American/Black and Hispanic persons living with HIV in the United States: a qualitative exploration.

Authors:  Robert Freeman; Marya Viorst Gwadz; Elizabeth Silverman; Alexandra Kutnick; Noelle R Leonard; Amanda S Ritchie; Jennifer Reed; Belkis Y Martinez
Journal:  Int J Equity Health       Date:  2017-03-24

9.  Implementation of "Treat-all" at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey.

Authors:  Ellen Brazier; Fernanda Maruri; Stephany N Duda; Olga Tymejczyk; C William Wester; Geoffrey Somi; Jeremy Ross; Aimee Freeman; Morna Cornell; Armel Poda; Beverly S Musick; Fujie Zhang; Keri N Althoff; Catrina Mugglin; April D Kimmel; Marcel Yotebieng; Denis Nash
Journal:  J Int AIDS Soc       Date:  2019-07       Impact factor: 5.396
  9 in total
  5 in total

1.  Five-Year Mortality for Adults Entering Human Immunodeficiency Virus Care Under Universal Early Treatment Compared With the General US Population.

Authors:  Jessie K Edwards; Stephen R Cole; Tiffany L Breger; Lindsey M Filiatreau; Lauren Zalla; Grace E Mulholland; Michael A Horberg; Michael J Silverberg; M John Gill; Peter F Rebeiro; Jennifer E Thorne; Parastu Kasaie; Vincent C Marconi; Timothy R Sterling; Keri N Althoff; Richard D Moore; Joseph J Eron
Journal:  Clin Infect Dis       Date:  2022-09-14       Impact factor: 20.999

2.  Timeliness of antiretroviral therapy initiation in the era before universal treatment.

Authors:  Nikolina Bogdanić; Liam Bendig; Davorka Lukas; Šime Zekan; Josip Begovac
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

3.  Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study.

Authors:  Jessie K Edwards; Stephen R Cole; Tiffany L Breger; Jacqueline E Rudolph; Lindsey M Filiatreau; Kate Buchacz; Elizabeth Humes; Peter F Rebeiro; Gypsyamber D'Souza; M John Gill; Michael J Silverberg; W Christopher Mathews; Michael A Horberg; Jennifer Thorne; H Irene Hall; Amy Justice; Vincent C Marconi; Viviane D Lima; Ronald J Bosch; Timothy R Sterling; Keri N Althoff; Richard D Moore; Michael Saag; Joseph J Eron
Journal:  Ann Intern Med       Date:  2021-07-06       Impact factor: 25.391

4.  Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.

Authors:  Diego A Rodríguez-Serrano; Emilia Roy-Vallejo; Isidoro González-Álvaro; Laura Cardeñoso; Nelly D Zurita Cruz; Alexandra Martín Ramírez; Sebastián C Rodríguez-García; Nuria Arevalillo-Fernández; José María Galván-Román; Leticia Fontán García-Rodrigo; Lorena Vega-Piris; Marta Chicot Llano; David Arribas Méndez; Begoña González de Marcos; Julia Hernando Santos; Ana Sánchez Azofra; Elena Ávalos Pérez-Urria; Pablo Rodriguez-Cortes; Laura Esparcia; Ana Marcos-Jimenez; Santiago Sánchez-Alonso; Irene Llorente; Joan Soriano; Carmen Suárez Fernández; Rosario García-Vicuña; Julio Ancochea; Jesús Sanz; Cecilia Muñoz-Calleja; Rafael de la Cámara; Alfonso Canabal Berlanga
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

5.  Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B.

Authors:  Yi-Wen Huang; Chao-Wei Hsu; Sheng-Nan Lu; Ming-Lung Yu; Chien-Wei Su; Wei-Wen Su; Rong-Nan Chien; Ching-Sheng Hsu; Shih-Jer Hsu; Hsueh-Chou Lai; Albert Qin; Kuan-Chiao Tseng; Pei-Jer Chen
Journal:  Hepatol Int       Date:  2020-10-24       Impact factor: 6.047
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.